title: Reduced cholecystokinin levels in the limbic lobe in schizophrenia. A marker for pathology underlying the defect state?
authors.forename: I N
authors.initials: IN
authors.lastname: Ferrier
authors.forename: T J
authors.initials: TJ
authors.lastname: Crow
authors.forename: S M
authors.initials: SM
authors.lastname: Farmery
authors.forename: G W
authors.initials: GW
authors.lastname: Roberts
authors.forename: F
authors.initials: F
authors.lastname: Owen
authors.forename: T E
authors.initials: TE
authors.lastname: Adrian
authors.forename: S R
authors.initials: SR
authors.lastname: Bloom
mesh_terms: D002766:Cholecystokinin / Q000032:analysis* / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism; D004569:Electroencephalography; D005260:Female; D006801:Humans; D008032:Limbic System / Q000032:analysis* / Q000473:pathology; D008297:Male; D009419:Nerve Tissue Proteins / Q000032:analysis; D011863:Radioimmunoassay; D011956:Receptors, Cell Surface / Q000032:analysis; D011949:Receptors, Cholecystokinin; D012559:Schizophrenia / Q000378:metabolism*
chemical_list: D009419:Nerve Tissue Proteins; D011956:Receptors, Cell Surface; D011949:Receptors, Cholecystokinin; D002766:Cholecystokinin; D004298:Dopamine